Organization
Jazz Pharmaceuticals, Philadelphia, PA
2 abstracts
Abstract
Real-world safety and healthcare resource utilization (HCRU) of lurbinectedin (lurbi) in patients (pts) with small cell lung cancer (SCLC): Jazz EMERGE 402 updated analysis.Org: Baptist Cancer Center, Memphis, TN, Rochester Regional Health, Rochester, NY, Carrie J. Babb Cancer Center, Bolivar, MO, Eastern Connecticut Hematology and Oncology Associates, Norwich, CT, Centre de Recherche de l’Institut Universitaire de Cardiologie et de Pneumologie de Québec – Université Laval, Québec, QC, Canada,
Abstract
Cardiotoxicity of CPX-351 vs 7+3 in patients with untreated high-risk acute myeloid leukemia.Org: Cardio-Oncology Center of Excellence, Washington University School of Medicine, St. Louis, MO, Heart and Vascular Institute, Penn State Hershey Medical Center, Hershey, PA, Jazz Pharmaceuticals, Philadelphia, PA, Jazz Pharmaceuticals, Palo Alto, CA, Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas, Kansas City, KS,